Mangoceuticals (MGRX) Total Current Liabilities (2022 - 2026)

Mangoceuticals has disclosed Total Current Liabilities across 5 years of filings, most recently posting $1.4 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 12.67% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (down 12.67% YoY), while the FY2025 annual figure was $890568.0, down 37.52% from the prior year.
• Total Current Liabilities came in at $1.4 million for Q2 2026 at Mangoceuticals, up from $737606.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $159176.0 in Q3 2023.
• Average Total Current Liabilities over 5 years is $890141.3, with a median of $890568.0 recorded in 2025.
• Year-over-year, Total Current Liabilities soared 774.12% in 2024 and plunged 50.93% in 2026.
• Over 5 years, Total Current Liabilities stood at $260577.0 in 2022, then fell by 19.0% to $211078.0 in 2023, then soared by 575.33% to $1.4 million in 2024, then sank by 37.52% to $890568.0 in 2025, then jumped by 56.99% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.4 million in Q2 2026, $737606.0 in Q1 2026, and $890568.0 in Q4 2025.